1-3 of 3
Donald H. Mahoney
Close
Sort by
Journal Articles

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

Clinical Trials & Observations Brief Report
Carolyn M. Bennett, Zora R. Rogers, Daniel D. Kinnamon, James B. Bussel, Donald H. Mahoney, Thomas C. Abshire, Hadi Sawaf, Theodore B. Moore, Mignon L. Loh, Bertil E. Glader, Maggie C. McCarthy, Brigitta U. Mueller, Thomas A. Olson, Adonis N. Lorenzana, William C. Mentzer, George R. Buchanan, Henry A. Feldman, Ellis J. Neufeld, the Pediatric Rituximab/ITP Study Group and the Glaser Pediatric Research Network
Journal: Blood
Blood (2006) 107 (7): 2639–2642.
https://doi.org/10.1182/blood-2005-08-3518
Published: 2006
Includes: Supplemental data
Journal Articles

The Safety and Efficacy of Oral Magnesium Pidolate in Children with Hemoglobin SC Disease.

Brigitta Ursula Mueller, MD, Marlen Dinu, MD, Susan Kurth, PNP, Roz Bryant, PNP, Elizabeth Mullen, MD, Yan Jinrong, Donald H. Mahoney, MD, Carlo Brugnara, MD
Journal: Blood
Blood (2005) 106 (11): 3777.
https://doi.org/10.1182/blood.V106.11.3777.3777
Published: 2005
Journal Articles

E2A-PBX1 Chimeric Transcript Status at End of Consolidation Is Not Predictive of Treatment Outcome in Childhood Acute Lymphoblastic Leukemias With a t(1;19)(q23;p13): A Pediatric Oncology Group Study

Stephen P. Hunger, Majilinde Z. Fall, Bruce M. Camitta, Andrew J. Carroll, Michael P. Link, Stephen J. Lauer, Donald H. Mahoney, D. Jeanette Pullen, Jonathan J. Shuster, C. Philip Steuber, Michael L. Cleary
Journal: Blood
Blood (1998) 91 (3): 1021–1028.
https://doi.org/10.1182/blood.V91.3.1021
Published: 1998